About The ASCO Post
Rights and Permissions
In the Clinic
View By Issue
2019 San Antonio Breast Cancer Symposium
2019 ASH Annual Meeting & Exposition
ESMO Immuno-Oncology Congress 2019
2019 Lynn Sage Breast Cancer Symposium
Biomarkers in Immunotherapy
Methotrexate–Induced Kidney Injury
The Policy, Politics
Today In Oncology
Society for Integrative Oncology’s 16th International Conference
Ovarian Tissue Cryopreservation to Preserve Fertility in Pediatric Patients With Cancer
Asciminib for Patients With CML After Failure of ABL Kinase Inhibitor Treatment
Screening Rates Rose Among People Age 45–49 After Release of Updated Colorectal Cancer Guidelines
Long-Term Results of IBIS-II
Most Read Stories
Does Adding Trastuzumab to Adjuvant Chemotherapy Improve Invasive Disease–Free Survival for Patients With HER2-Negative Breast Cancer?
Dietary Supplement Use During Adjuvant Chemotherapy and Treatment Outcomes in Patients With Early Breast Cancer
Management of HER2-Positive Breast Cancer: Business as Usual?
Entrectinib in Advanced or Metastatic
Fusion–Positive Solid Tumors
Does Statin Use Increase Overall Survival in Patients With Colorectal Cancer?
Most Viewed Videos
Nadine M. Tung, MD, on HER2-Negative Breast Cancer: INFORM Trial of Cisplatin vs Doxorubicin/Cyclophosphamide
Nitin Jain, MD, on First-Line Ibrutinib Plus Venetoclax in CLL
C. Ola Landgren, MD, PhD, on Carfilzomib, Lenalidomide, Dexamethasone, and Daratumumab for Newly Diagnosed Multiple Myeloma
Ariella B. Hanker, PhD, on Therapeutic Implications of HER2 and HER3 Mutations in Breast Cancer
Frederick L. Locke, MD, on Innovative CAR-T Cell Therapies: The Patient Experience
© 2020 HSP News Service, L.L.C.